The market for weight loss drugs is white-hot, and competition is heating up fast. This Danish company is already facing a ...

Here is my list of three expert market predictions for May 2025, including insights on yields and job market trends. Read ...

Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following ...

In our analysis, these brokerage accounts stand out as the best choices for stock trading, due to their low fees, strong platforms and quality customer support. Many or all of the products on this ...

Pfizer recently said it wouldn't continue development of its weight loss candidate danuglipron, a once-daily pill, after a ...

Viking Therapeutics (VKTX) stock rises as Pfizer (PFE) plans to bolster its pipeline with cardiometabolic and other obesity drugs, through acquisitions. Read more here.

Novo Nordisk NVO is expected to beat estimates when it reports its first-quarter 2025 results before the opening bell on May ...

Fintel reports that on April 28, 2025, Cantor Fitzgerald initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a ...

The theory goes like this: Lee cut his price target on Viking from $95 to $75 a share, warning the company faces "intensifying competition in the obesity space" (as The Fly reports today). Yet even so ...

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance ...

According to TipRanks.com, Windley is a 5-star analyst with an average return of 9.6% and a 59.7% success rate. Windley covers the Healthcare sector, focusing on stocks such as Charles River Labs, ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...